182 related articles for article (PubMed ID: 35216581)
61. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.
Dubey AK; Sahoo J; Vairappan B; Haridasan S; Parameswaran S; Priyamvada PS
Nephrol Dial Transplant; 2020 Jan; 35(1):121-129. PubMed ID: 30053298
[TBL] [Abstract][Full Text] [Related]
62. Management of Metabolic Acidosis in Chronic Kidney Disease: Past, Present, and Future Direction.
Goraya N; Narayanan M; Wesson DE
Adv Chronic Kidney Dis; 2022 Jul; 29(4):416-423. PubMed ID: 36175079
[TBL] [Abstract][Full Text] [Related]
63. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.
Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183
[TBL] [Abstract][Full Text] [Related]
64. Acid retention in chronic kidney disease is inversely related to GFR.
Goraya N; Simoni J; Sager LN; Pruszynski J; Wesson DE
Am J Physiol Renal Physiol; 2018 May; 314(5):F985-F991. PubMed ID: 29357423
[TBL] [Abstract][Full Text] [Related]
65. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE
Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657
[TBL] [Abstract][Full Text] [Related]
66. Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.
Tyson CC; Luciano A; Modliszewski JL; Corcoran DL; Bain JR; Muehlbauer M; Ilkayeva O; Pourafshar S; Allen J; Bowman C; Gung J; Asplin JR; Pendergast J; Svetkey LP; Lin PH; Scialla JJ
Am J Kidney Dis; 2021 Jul; 78(1):38-47. PubMed ID: 33810868
[TBL] [Abstract][Full Text] [Related]
67. The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D.
Beaubien-Souligny W; Bezzaoucha S; Pichette V; Lafrance JP; Bell R; Lamarche C; Ouimet D; Vallee M
Int Urol Nephrol; 2015 Jul; 47(7):1165-71. PubMed ID: 25982583
[TBL] [Abstract][Full Text] [Related]
68. Metabolic Acidosis in CKD: Core Curriculum 2019.
Raphael KL
Am J Kidney Dis; 2019 Aug; 74(2):263-275. PubMed ID: 31036389
[TBL] [Abstract][Full Text] [Related]
69. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
[TBL] [Abstract][Full Text] [Related]
70. Gap acidosis except lactic acidosis develops and progresses during chronic kidney disease stage G5.
Tanemoto M
Clin Exp Nephrol; 2019 Aug; 23(8):1045-1049. PubMed ID: 31062197
[TBL] [Abstract][Full Text] [Related]
71. Importance of Metabolic Acidosis as a Health Risk in Chronic Kidney Disease.
Vincent-Johnson A; Scialla JJ
Adv Chronic Kidney Dis; 2022 Jul; 29(4):329-336. PubMed ID: 36175070
[TBL] [Abstract][Full Text] [Related]
72. Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial.
Mathur RP; Dash SC; Gupta N; Prakash S; Saxena S; Bhowmik D
Ren Fail; 2006; 28(1):1-5. PubMed ID: 16526312
[TBL] [Abstract][Full Text] [Related]
73. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients.
Kanda E; Ai M; Yoshida M; Kuriyama R; Shiigai T
BMC Nephrol; 2013 Jan; 14():4. PubMed ID: 23298330
[TBL] [Abstract][Full Text] [Related]
74. The evaluation of the relationship between serum levels of Interleukin-6 and Interleukin-10 and metabolic acidosis in hemodialysis patients.
Zahed NS; Chehrazi S
Saudi J Kidney Dis Transpl; 2017; 28(1):23-29. PubMed ID: 28098099
[TBL] [Abstract][Full Text] [Related]
75. Bicarbonate Concentration, Acid-Base Status, and Mortality in the Health, Aging, and Body Composition Study.
Raphael KL; Murphy RA; Shlipak MG; Satterfield S; Huston HK; Sebastian A; Sellmeyer DE; Patel KV; Newman AB; Sarnak MJ; Ix JH; Fried LF;
Clin J Am Soc Nephrol; 2016 Feb; 11(2):308-16. PubMed ID: 26769766
[TBL] [Abstract][Full Text] [Related]
76. [Treatment of metabolic acidosis in patients with chronic kidney disease (CKD)].
Dębowska M; Przedlacki J
Wiad Lek; 2017; 70(6 pt 2):1197-1200. PubMed ID: 29533913
[TBL] [Abstract][Full Text] [Related]
77. Effects of Oral Bicarbonate Supplementation on the Cardiovascular Risk Factors and Serum Nutritional Markers in Non-Dialysed Chronic Kidney Disease Patients.
Szczecińska K; Wajdlich M; Nowicka M; Nowicki M; Kurnatowska I
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454357
[TBL] [Abstract][Full Text] [Related]
78. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study.
Chen W; Melamed ML; Hostetter TH; Bauer C; Raff AC; Almudevar AL; Lalonde A; Messing S; Abramowitz MK
BMC Nephrol; 2016 Aug; 17(1):114. PubMed ID: 27495287
[TBL] [Abstract][Full Text] [Related]
79. Influence of rapid correction of metabolic acidosis on serum osteocalcin level in chronic renal failure.
Lin YF; Shieh SD; Diang LK; Lin SH; Chyr SH; Li BL; Lu KC
ASAIO J; 1994; 40(3):M440-4. PubMed ID: 8555554
[TBL] [Abstract][Full Text] [Related]
80. Consequences and therapy of the metabolic acidosis of chronic kidney disease.
Kraut JA; Madias NE
Pediatr Nephrol; 2011 Jan; 26(1):19-28. PubMed ID: 20526632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
